Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Rangering i aksjer #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Aksjekurs
$0.05124204
Markedsverdi
$7.78M
Endring (1 dag)
0.51%
Endring (1 år)
-23.73%
Land
CH
Handel Addex Therapeutics Ltd (ADXN)

Kategori

Aksjeprishistorikk for Addex Therapeutics Ltd (ADXN)
Høyeste sluttskurs: $0.05 den 2026-08-01

Laveste sluttskurs: $54.79 den 2007-05-01
Aksjeprishistorikk for Addex Therapeutics Ltd fra 2007 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -6.77%
2025 5.69%
2024 28.65%
2023 -59.04%
2022 -89.21%
2021 -42.01%
2020 15.05%
2019 -25.63%
2018 1.94%
2017 22.36%
2016 -37.32%
2015 15.45%
2014 -35.66%
2013 -62.43%
2012 68.65%
2011 -41.91%
2010 -59.41%
2009 -21.49%
2008 -3.22%
2007 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$736.12 7.12%
CH
$1.07K -6.40%
KR
$255.38 13.33%
BE